Brittany Moates, OD
Optometrist · Lawrenceville, GANPI 1538658091
Payments from drug & device makers
Across 135 payments — averaging $43.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$1K
- Harrow Eye, LLC$649
- Johnson & Johnson Surgical Vision, Inc.$511
- Alcon$472
- AbbVie$367
- Tarsus Pharmaceuticals, Inc.$356
- plus $2K from 15 others
What the payments were for
- Travel & lodging$58310%
- Food & beverage$5,23790%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 12 | $1,119 |
| Harrow Eye, LLC | 13 | $649 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $511 |
| Alcon | 9 | $472 |
| AbbVie(2 entities) | 14 | $367 |
| Tarsus Pharmaceuticals, Inc. | 8 | $356 |
| Oyster Point Pharma, Inc. | 7 | $332 |
| Amgen(2 entities) | 11 | $329 |
| Bausch & Lomb Americas Inc. | 9 | $294 |
| Dompe US, Inc. | 8 | $268 |
| Sun Pharmaceutical Industries Inc. | 8 | $219 |
| Johnson & Johnson Vision Care, Inc. | 10 | $175 |
| Novartis | 4 | $164 |
| Thea Pharma Inc. | 4 | $163 |
| Glaukos Corporation | 3 | $148 |
| Sight Sciences, Inc. | 4 | $83 |
| Coopervision Inc. | 1 | $61 |
| Rxsight Inc | 1 | $49 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| NEW World Medical,inc. | 1 | $21 |
| Carl Zeiss Meditec USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$955
- AmnioGraft$840
- Tecnis IOL$511
- TYRVAYA$227
- VEVYE$223
- XDEMVY$222
- MIEBO$122
- XIIDRA$122
- Rhopressa$121
- Rocklatan$121
- SIMBRINZA$121
- Tecnis Simplicity$115
- Hydrus Microstent$110
- Oxervate$110
- TRAVATAN Z$105
How this compares
$5,821 in reported general payments places this provider in the 90th percentile of 1,285 optometrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 80 | $107,607 |
| XiidraLifitegrast | 53 | $63,640 |
| XdemvyLotilaner | 15 | $27,987 |
| LumiganBimatoprost | 62 | $23,751 |
| MieboPerfluorohexyloctane/Pf | 22 | $16,502 |
| Cyclosporine | 12 | $7,154 |
| IlevroNepafenac | 15 | $5,531 |
| CombiganBrimonidine Tartrate/Timolol | 25 | $5,169 |
| Loteprednol Etabonate | 30 | $4,725 |
| Bromfenac Sodium | 32 | $4,106 |
| Prednisolone Acetate | 108 | $3,815 |
| Travatan ZTravoprost | 15 | $3,773 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 17 | $3,413 |
| Brimonidine Tartrate | 86 | $3,080 |
| Latanoprost | 259 | $2,246 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $367 | $136,526167 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $294 | $80,14275 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $356 | $27,98715 claims |
| NovartisIlevro, Travatan Z | $164 | $9,30530 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $22 | $4,72530 claims |
| AlconSimbrinza | $472 | $3,41317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,285 optometrist providers in Georgia.
Other optometrist in Lawrenceville
- Anne BrobstDuluth$1.2M
- Michael HungCumming$1.2M
- Joshua JohnstonAtlanta$997K
- John WomackCanton$931K
- David WinnerRoswell$877K
- Lauren HackerGreensboro$511K
- Katherine WooAtlanta$336K
- Naheed AhmadRoswell$296K
- Stephanie RossAtlanta$283K
- Scott MoscowRoswell$278K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.